
Type
Child
Status
Approved
Title (YouTube)
Images Failed (Social)
Do not index
Parent item
Publish Date (TikTok)
Videos Post IDs (Social)
Hashtags (Social)
Caption
Caption X
Alt Image Text
Flat vector illustration of a Gatorade recall over undeclared yellow dyes, showing sports drink bottles, label inspection, and warning cues in a minimal modern style.
Images
Videos
Publish Date (Social)
Scheduled (Social)
Images Posted (Social)
Videos Posted (Social)
Featured
Created time
Oct 8, 2026 03:39 PM
Sub-item
Authors
CTA Practice Area (Social)
TikTok Failed (Social)
Videos Post Links (Social)
TikTok Post Links (Social)
Images Post IDs (Social)
YT Post ID
Video Pending Manual (Social)
TikTok Posted (Social)
TikTok Post IDs (Social)
Video Cover (Social)
Images Post Links (Social)
First Comment (Social)
Videos Failed (Social)
YT Embedded
Images Delete (Social)
Videos Delete (Social)
Carousel Video URL (Social)
PepsiCo has recalled more than 122,000 cases of 28-ounce Gatorade sold across 37 states after discovering that certain Lemon Lime, Lemon Lime Zero, Orange, and Orange Zero bottles contained undeclared Yellow No. 5 and Yellow No. 6. The U.S. Food and Drug Administration classified the action as a Class II recall on October 2, 2026, following PepsiCo’s voluntary recall dated September 25, 2026, according to the FDA’s recall classification system and multiple reports describing the affected Gatorade lots.
According to news reports summarizing the agency’s notice, the recall covers 122,021 cases and involves products distributed in 37 states, with no illnesses publicly reported so far. The issue centers on undeclared Yellow No. 5 and Yellow No. 6, which can matter for consumers who are allergic or otherwise sensitive to those color additives.
Background On Why A Labeling Recall Matters
At first glance, a food-and-drink recall over color additives may sound technical. In legal terms, though, ingredient labeling sits at the center of consumer protection and food safety compliance.
The FDA describes a Class II recall as a situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious harm is remote. That classification appears especially relevant here because the concern is not that every bottle is dangerous to every consumer, but that the undeclared dyes on the product labels could pose a meaningful issue for a narrower group of consumers.
FDA materials also explain that recalls often begin with a company’s voluntary action and are later classified by the agency after a hazard assessment. In other words, the September 25 recall date and the October 2 classification date are not inconsistent; they reflect the FDA’s recall process, where a company initiates the removal and the agency later assigns a class.
For consumers, the practical concern is straightforward: labels are how people screen for allergens, sensitivities, dietary restrictions, and ingredients they prefer to avoid. FDA guidance notes that undeclared color additives have triggered enforcement before, and the agency treats food color disclosure requirements as a real compliance issue rather than a minor packaging defect.
The Products At Issue
The recall involves 28-ounce bottles of four varieties: Gatorade Lemon Lime, Gatorade Zero Lemon Lime, Gatorade Orange, and Gatorade Zero Orange. Reports indicate the products bear specific lot codes and best-by dates, which is significant because this is not a brand-wide withdrawal. It is a lot-specific recall tied to identified production runs.
That distinction may become important if disputes emerge later. In many product cases, liability questions turn on exactly which units were sold, where they were distributed, what the label said at the time of sale, and whether a consumer can connect a purchase to an affected lot.
Why This Could Draw Legal Attention Beyond The Recall Itself
The recall arrives at a time when Gatorade is already facing consumer litigation over how some products are marketed. Separate lawsuits filed in 2026 allege that certain Gatorade labeling and advertising overstated hydration benefits and misled consumers about artificial ingredients, according to publicly available records involving pending federal class actions against PepsiCo and The Gatorade Company and reporting on claims about hydration and artificial ingredients.
That does not mean this recall automatically proves any separate lawsuit. Recalls and civil claims often involve different legal standards, different product lines, and different evidence. Still, plaintiff attorneys frequently view recall activity as a potential data point in larger arguments about labeling accuracy, quality control, internal oversight, and whether a company’s disclosures matched what consumers actually received.
Here, the core issue appears narrower than some advertising cases: the label allegedly omitted the presence of certain dyes in certain lots. But in the broader consumer-law landscape, that kind of omission can overlap with theories involving deceptive practices, breach of warranty, unjust enrichment, or violations of state consumer-protection statutes. An attorney might help affected buyers determine whether the recall remains a stand-alone event or becomes part of a wider litigation pattern.
What Affected Consumers May Be Looking At
For many households, the first question is practical rather than legal: is the product sitting in the pantry or garage one of the recalled bottles? Reports indicate the products were shipped widely, and the recall’s size suggests many consumers may still have the four 28-ounce varieties covered by the recall.
For people with dye sensitivities or allergy concerns, the legal significance often starts with documentation. In product matters, records such as receipts, bottle photos, lot codes, best-by dates, retailer information, and any medical treatment can become relevant later. Even where no physical injury is reported, consumers sometimes explore claims tied to economic loss, mislabeled purchases, or refund rights, depending on state law and the facts surrounding the sale.
Some consumers may also wonder whether “no illnesses reported” ends the story. Often it does not. A recall can trigger legal questions even without confirmed injuries, especially when the dispute centers on labeling accuracy, omission of ingredients, or whether consumers paid for something different from what the label represented. On the other hand, the absence of reported illnesses could affect the scale and direction of any future claims.
What Retailers And Distributors May Consider
Retailers, wholesalers, and convenience stores can face a different set of issues. Once a recall is underway, businesses often review inventory controls, removal procedures, customer notice practices, and communications with suppliers. Depending on the contracts involved, downstream sellers may also look at indemnity provisions, return arrangements, and recordkeeping tied to the recalled stock.
In food-and-beverage cases, supply-chain records can become important quickly. If a dispute grows into insurance claims, reimbursement demands, or consumer litigation, businesses may find that the FDA’s enforcement-report framework and the company’s own recall notices become central reference points.
The Bigger Consumer Protection Question
This Gatorade recall is, on one level, a classic labeling case: an ingredient disclosure problem affecting a defined set of bottles. But it also highlights a bigger question in modern consumer law—how much precision companies are expected to maintain between formulation, packaging, and public-facing marketing.
In highly distributed consumer products, even a lot-specific labeling failure can create ripple effects far beyond the original production line. Regulators may focus on public health risk. Consumers may focus on trust and transparency. Plaintiffs’ lawyers may focus on whether internal controls caught the issue soon enough. Defense counsel may focus on the limited scope, the voluntary recall, and the absence of reported injuries.
All of those perspectives can exist at once.
For now, the publicly reported facts point to a nationwide labeling recall with a moderate FDA classification, no publicly reported illnesses, and a potentially significant footprint because of the number of cases involved. Whether that develops into additional lawsuits may depend on what emerges about distribution, consumer complaints, internal quality checks, and whether affected purchasers can show measurable harm.
If you're facing legal challenges, ReferU.AI analyzes billions of court records to match you with attorneys who've successfully represented cases just like yours.


